Cargando…
Regulation of complement and modulation of its activity in monoclonal antibody therapy of cancer
The complement system is a powerful tool of the innate immune system to eradicate pathogens. Both in vitro and in vivo evidence indicates that therapeutic anti-tumor monoclonal antibodies (mAbs) can activate the complement system by the classical pathway. However, the contribution of complement to t...
Autores principales: | Meyer, Saskia, Leusen, Jeanette HW, Boross, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4622586/ https://www.ncbi.nlm.nih.gov/pubmed/25517299 http://dx.doi.org/10.4161/mabs.29670 |
Ejemplares similares
-
Improved in vivo anti-tumor effects of IgA-Her2 antibodies through half-life extension and serum exposure enhancement by FcRn targeting
por: Meyer, Saskia, et al.
Publicado: (2015) -
ARGX-117, a therapeutic complement inhibiting antibody targeting C2
por: Van de Walle, Inge, et al.
Publicado: (2020) -
Effect of a tail piece cysteine deletion on biochemical and functional properties of an epidermal growth factor receptor-directed IgA2 m(1) antibody
por: Brunke, Christina, et al.
Publicado: (2013) -
Anti-C2 Antibody ARGX-117 Inhibits Complement in a Disease Model for Multifocal Motor Neuropathy
por: Budding, Kevin, et al.
Publicado: (2021) -
Complement receptor 3 mediates both sinking phagocytosis and phagocytic cup formation via distinct mechanisms
por: Walbaum, Stefan, et al.
Publicado: (2021)